To demonstrate the clinical relevance of these correlations, we evaluated the expression level of ARID1A, p-CHK1S345, ssDNA and tumor PD-L1 in CRC patients by immunohistochemical analysis (Fig. 6I). The gene discussed is ARID1A; the disease is neoplasm.